From mitochondrial dysfunction to neuroinflammation in Parkinson’s disease: Pathogenesis and mitochondrial therapeutic approaches
Article in International Immunopharmacology (September 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson’s disease
Article in Molecular Diversity (August 2024)
Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
Article in Frontiers in Bioscience-Landmark (January 2024)